Pre-exercise inhalation of short-acting ß-agonists (SABA) safely improves exercise performance in severe COPD patients by reducing lung hyperinflation Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010
Degree of exercise limitation in COPD: impact on 6 minute walk (6MW) in response to long-acting β-agonist (LABA) treatment Source: Eur Respir J 2007; 30: Suppl. 51, 76s Year: 2007
Inhaled vilanterol trifenatate/fluticasone furoate increases maximum diaphragm contraction in severe COPD Source: International Congress 2014 – Clinical physiology and respiratory muscles Year: 2014
Inhaled vilanterol trifenatate/fluticasone furoate (VFF) improves respiratory muscle function and walking performance in severe COPD without change in pulmonary function Source: International Congress 2017 – Management of COPD Year: 2017
Effects of supplemental oxygen and high-dose inhaled bronchodilator therapy in exercise performance and dyspnoea in patients with stable COPD Source: Annual Congress 2004 - Exercise and systemic effects in COPD Year: 2004
Acute bronchodilator responsiveness in a global respiratory trial (UPLIFT) following maximal inhaled bronchodilators Source: Eur Respir J 2005; 26: Suppl. 49, 716s Year: 2005
Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD Source: Eur Respir J 2009; 33: 771-777 Year: 2009
Effects during exercise of non-invasive ventilation for improving exercise ability in restrictive chronic respiratory failure (RCRF) Source: Eur Respir J 2006; 28: Suppl. 50, 185s Year: 2006
Endurance shuttle walking test: responsiveness to salmeterol in COPD Source: Eur Respir J 2008; 31: 579-584 Year: 2008
Improvement in respiratory muscle O2 delivery by Heliox or pure O2 breathing is associated with reduced dyspnea sensations during exercise in COPD Source: International Congress 2016 – Dyspnoea and respiratory muscle/mechanics anomalies in disease Year: 2016
Effect of inspiratory pressure-threshold loading on the respiratory response to incremental exercise Source: International Congress 2014 – Clinical exercise physiology in health and COPD Year: 2014
Exercise testing in children with respiratory diseases Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-49-5, page=186 Year: 2007
Exertional dyspnea relief following bronchodilation in COPD: Role of neural respiratory drive Source: International Congress 2015 – Clinical physiology: from airways, lung and respiratory muscles to dyspnoea in health and disease Year: 2015
Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015
Arm training: effects on ventilatory response to unsupported arm exercise (UAEx) in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 608s Year: 2006
Anabolic response during incremental and constant work rate exercise testing in COPD patients after an acute exacerbation (AE) Source: Eur Respir J 2002; 20: Suppl. 38, 565s Year: 2002
Respiratory muscle strength and perception of dyspnea during bronchodilator response test in patients with stable COPD Source: Annual Congress 2008 - Respiratory muscles in disease Year: 2008
Respiratory muscle training (REMT) with normocapnic hyperpnoea (NH) improves respiratory muscle strength, exercise performance and ventilatory pattern in COPD patients Source: Annual Congress 2012 - Limiting factors in exercise Year: 2012
Pulsed inhaled nitric oxide (iNO) improves exercise tolerance and shortness of breath (SOB) in severe COPD subjects with pulmonary hypertension (PH) Source: International Congress 2018 – Advances in exercise physiopathology Year: 2018
Respiratory muscle training with normocapnic hyperpnoea (RMNH) improves ventilatory pattern, thoraco-abdominal coordination and reduces oxygen desaturation during exercise in COPD patients Source: International Congress 2014 – Mechanisms of exercise limitation in disease Year: 2014